Free Trial
NASDAQ:VIVK

Vivakor (VIVK) Stock Price, News & Analysis

Vivakor logo
$0.79 +0.04 (+5.32%)
Closing price 03:58 PM Eastern
Extended Trading
$0.79 +0.00 (+0.01%)
As of 07:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Vivakor Stock (NASDAQ:VIVK)

Key Stats

Today's Range
$0.74
$0.82
50-Day Range
$0.64
$1.12
52-Week Range
$0.55
$3.45
Volume
25,714 shs
Average Volume
51,997 shs
Market Capitalization
$35.21 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Vivakor, Inc. operates, acquires, and develops technologies and assets in the oil and gas industry and related environmental solutions in the United States and Kuwait. The company owns and operates a crude oil gathering, storage, and transportation facility in Delhi, Louisiana. It also owns a crude oil storage tank located near Colorado City, Texas. In addition, the company offers remediation of soil and the extraction of hydrocarbons, such as oil from properties contaminated by or laden with heavy crude oil and other hydrocarbon-based substances. The company was formerly known as NGI Holdings, LLC and changed its name to Vivakor, Inc. in April 2008. The company was incorporated in 2006 and is based in Dallas, Texas.

Vivakor Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
9th Percentile Overall Score

VIVK MarketRank™: 

Vivakor scored higher than 9% of companies evaluated by MarketBeat, and ranked 306th out of 315 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Vivakor.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Vivakor is -1.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Vivakor is -1.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Vivakor has a P/B Ratio of 1.20. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Vivakor's valuation and earnings.
  • Percentage of Shares Shorted

    0.30% of the float of Vivakor has been sold short.
  • Short Interest Ratio / Days to Cover

    Vivakor has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Vivakor has recently decreased by 0.18%, indicating that investor sentiment is improving.
  • Dividend Yield

    Vivakor does not currently pay a dividend.

  • Dividend Growth

    Vivakor does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.30% of the float of Vivakor has been sold short.
  • Short Interest Ratio / Days to Cover

    Vivakor has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Vivakor has recently decreased by 0.18%, indicating that investor sentiment is improving.
  • Search Interest

    1 people have searched for VIVK on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Vivakor insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    47.84% of the stock of Vivakor is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 12.31% of the stock of Vivakor is held by institutions.

  • Read more about Vivakor's insider trading history.
Receive VIVK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vivakor and its competitors with MarketBeat's FREE daily newsletter.

VIVK Stock News Headlines

Trump to redistribute trillions of dollars
Seeing how the media and other analysts are covering Trump’s actions – it’s laughable. At least it would be laughable if it wasn’t putting so many Americans’ financial futures at severe risk… That’s why, with the 100-day mark of Trump’s second term just days away, it’s time to shine a light on what’s really going on, because if you move your money out of the wrong places and into the right ones before it’s too late… …you could be one of the few who profits from this imminent trillion-dollar reset.
Vivakor withdraws preferred stock series
Vivakor Expands Omega Pipeline System in Oklahoma
Vivakor Revises Merger Timeline with Empire Diversified
See More Headlines

VIVK Stock Analysis - Frequently Asked Questions

Vivakor's stock was trading at $1.22 at the start of the year. Since then, VIVK shares have decreased by 35.3% and is now trading at $0.7899.
View the best growth stocks for 2025 here
.

Vivakor, Inc. (NASDAQ:VIVK) posted its quarterly earnings data on Tuesday, April, 15th. The company reported ($0.24) earnings per share for the quarter. The firm had revenue of $41.69 million for the quarter. Vivakor had a negative net margin of 17.30% and a negative trailing twelve-month return on equity of 66.05%.

Vivakor (VIVK) raised $8 million in an IPO on the week of February 14th 2022. The company issued 1,500,000 shares at $4.50-$6.50 per share. EF Hutton served as the underwriter for the IPO.

Shares of VIVK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vivakor investors own include Meta Platforms (META), Alnylam Pharmaceuticals (ALNY), Amgen (AMGN), Artelo Biosciences (ARTL), Avenue Therapeutics (ATXI), AstraZeneca (AZN) and Constellation Energy (CEG).

Company Calendar

Last Earnings
4/15/2025
Today
5/08/2025
Next Earnings (Estimated)
5/19/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Refuse systems
Sub-Industry
Business Services
Current Symbol
NASDAQ:VIVK
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-10,740,000.00
Pretax Margin
-16.62%

Debt

Sales & Book Value

Annual Sales
$89.81 million
Price / Cash Flow
N/A
Book Value
$0.66 per share
Price / Book
1.20

Miscellaneous

Free Float
21,390,000
Market Cap
$35.21 million
Optionable
Not Optionable
Beta
1.06
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:VIVK) was last updated on 5/8/2025 by MarketBeat.com Staff
From Our Partners